1	the	_	The	_	DT	0	_	_	_	_	_	_	_	O
2	timing	_	UNK	_	NN	0	_	_	_	_	_	_	_	O
3	of	_	of	_	IN	0	_	_	_	_	_	of.prep	Age	O
4	unk	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
5	alliances	_	UNK	_	NNPS	0	_	_	_	_	_	_	_	O
6	in	_	in	_	IN	0	_	_	_	_	_	_	_	O
7	new	_	New	_	NNP	0	_	_	_	_	_	_	_	O
8	product	_	UNK	_	NNP	0	_	_	_	_	_	_	_	O
9	development	_	Development	_	NNP	0	_	_	_	_	_	_	_	O

1	upstream	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
2	biotech	_	biotech	_	NN	1	_	_	_	_	_	_	_	O
3	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
4	(	_	(	_	(	1	_	_	_	_	_	_	_	O
5	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
6	,	_	,	_	,	1	_	_	_	_	_	_	_	O
7	upstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
8	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
9	)	_	)	_	)	1	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
11	downstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
12	pharmaceutical	_	pharmaceutical	_	JJ	1	_	_	_	_	_	_	_	O
13	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
14	(	_	(	_	(	1	_	_	_	_	_	_	_	O
15	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
16	,	_	,	_	,	1	_	_	_	_	_	_	_	O
17	downstream	_	UNK	_	FW	1	_	_	_	_	_	_	_	O
18	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
19	)	_	)	_	)	1	_	_	_	_	_	_	_	O
20	often	_	often	_	RB	1	_	_	_	_	_	often.adv	Frequency	O
21	form	_	form	_	JJ	1	_	_	_	_	_	_	_	O
22	alliances	_	alliance	_	NNS	1	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
24	cope	_	UNK	_	VB	1	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
26	performance	_	performance	_	NN	1	_	_	_	_	_	_	_	O
27	uncertainty	_	uncertainty	_	NN	1	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
30	exploit	_	exploit	_	VB	1	_	_	_	_	_	_	_	O
31	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
32	specificity	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
33	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
34	new	_	new	_	JJ	1	_	_	_	_	_	_	_	O
35	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
36	development	_	development	_	NN	1	_	_	_	_	_	_	_	O
37	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	upstream	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
2	biotech	_	biotech	_	NN	1	_	_	_	_	_	_	_	O
3	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
4	(	_	(	_	(	1	_	_	_	_	_	_	_	O
5	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
6	,	_	,	_	,	1	_	_	_	_	_	_	_	O
7	upstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
8	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
9	)	_	)	_	)	1	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
11	downstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
12	pharmaceutical	_	pharmaceutical	_	JJ	1	_	_	_	_	_	_	_	O
13	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
14	(	_	(	_	(	1	_	_	_	_	_	_	_	O
15	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
16	,	_	,	_	,	1	_	_	_	_	_	_	_	O
17	downstream	_	UNK	_	FW	1	_	_	_	_	_	_	_	O
18	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
19	)	_	)	_	)	1	_	_	_	_	_	_	_	O
20	often	_	often	_	RB	1	_	_	_	_	_	_	_	O
21	form	_	form	_	JJ	1	_	_	_	_	_	_	_	O
22	alliances	_	alliance	_	NNS	1	_	_	_	_	_	alliance.n	Alliance	O
23	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
24	cope	_	UNK	_	VB	1	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
26	performance	_	performance	_	NN	1	_	_	_	_	_	_	_	O
27	uncertainty	_	uncertainty	_	NN	1	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
30	exploit	_	exploit	_	VB	1	_	_	_	_	_	_	_	O
31	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
32	specificity	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
33	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
34	new	_	new	_	JJ	1	_	_	_	_	_	_	_	O
35	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
36	development	_	development	_	NN	1	_	_	_	_	_	_	_	O
37	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	upstream	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
2	biotech	_	biotech	_	NN	1	_	_	_	_	_	_	_	O
3	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
4	(	_	(	_	(	1	_	_	_	_	_	_	_	O
5	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
6	,	_	,	_	,	1	_	_	_	_	_	_	_	O
7	upstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
8	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
9	)	_	)	_	)	1	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
11	downstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
12	pharmaceutical	_	pharmaceutical	_	JJ	1	_	_	_	_	_	_	_	O
13	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
14	(	_	(	_	(	1	_	_	_	_	_	_	_	O
15	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
16	,	_	,	_	,	1	_	_	_	_	_	_	_	O
17	downstream	_	UNK	_	FW	1	_	_	_	_	_	_	_	O
18	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
19	)	_	)	_	)	1	_	_	_	_	_	_	_	O
20	often	_	often	_	RB	1	_	_	_	_	_	_	_	O
21	form	_	form	_	JJ	1	_	_	_	_	_	_	_	O
22	alliances	_	alliance	_	NNS	1	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	1	_	_	_	_	_	to.prep	Goal	O
24	cope	_	UNK	_	VB	1	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
26	performance	_	performance	_	NN	1	_	_	_	_	_	_	_	O
27	uncertainty	_	uncertainty	_	NN	1	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
30	exploit	_	exploit	_	VB	1	_	_	_	_	_	_	_	O
31	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
32	specificity	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
33	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
34	new	_	new	_	JJ	1	_	_	_	_	_	_	_	O
35	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
36	development	_	development	_	NN	1	_	_	_	_	_	_	_	O
37	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	upstream	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
2	biotech	_	biotech	_	NN	1	_	_	_	_	_	_	_	O
3	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
4	(	_	(	_	(	1	_	_	_	_	_	_	_	O
5	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
6	,	_	,	_	,	1	_	_	_	_	_	_	_	O
7	upstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
8	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
9	)	_	)	_	)	1	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
11	downstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
12	pharmaceutical	_	pharmaceutical	_	JJ	1	_	_	_	_	_	_	_	O
13	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
14	(	_	(	_	(	1	_	_	_	_	_	_	_	O
15	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
16	,	_	,	_	,	1	_	_	_	_	_	_	_	O
17	downstream	_	UNK	_	FW	1	_	_	_	_	_	_	_	O
18	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
19	)	_	)	_	)	1	_	_	_	_	_	_	_	O
20	often	_	often	_	RB	1	_	_	_	_	_	_	_	O
21	form	_	form	_	JJ	1	_	_	_	_	_	_	_	O
22	alliances	_	alliance	_	NNS	1	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
24	cope	_	UNK	_	VB	1	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
26	performance	_	performance	_	NN	1	_	_	_	_	_	performance.n	Performing_arts	O
27	uncertainty	_	uncertainty	_	NN	1	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
30	exploit	_	exploit	_	VB	1	_	_	_	_	_	_	_	O
31	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
32	specificity	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
33	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
34	new	_	new	_	JJ	1	_	_	_	_	_	_	_	O
35	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
36	development	_	development	_	NN	1	_	_	_	_	_	_	_	O
37	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	upstream	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
2	biotech	_	biotech	_	NN	1	_	_	_	_	_	_	_	O
3	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
4	(	_	(	_	(	1	_	_	_	_	_	_	_	O
5	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
6	,	_	,	_	,	1	_	_	_	_	_	_	_	O
7	upstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
8	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
9	)	_	)	_	)	1	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
11	downstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
12	pharmaceutical	_	pharmaceutical	_	JJ	1	_	_	_	_	_	_	_	O
13	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
14	(	_	(	_	(	1	_	_	_	_	_	_	_	O
15	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
16	,	_	,	_	,	1	_	_	_	_	_	_	_	O
17	downstream	_	UNK	_	FW	1	_	_	_	_	_	_	_	O
18	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
19	)	_	)	_	)	1	_	_	_	_	_	_	_	O
20	often	_	often	_	RB	1	_	_	_	_	_	_	_	O
21	form	_	form	_	JJ	1	_	_	_	_	_	_	_	O
22	alliances	_	alliance	_	NNS	1	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
24	cope	_	UNK	_	VB	1	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
26	performance	_	performance	_	NN	1	_	_	_	_	_	_	_	O
27	uncertainty	_	uncertainty	_	NN	1	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	1	_	_	_	_	_	to.prep	Goal	O
30	exploit	_	exploit	_	VB	1	_	_	_	_	_	_	_	O
31	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
32	specificity	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
33	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
34	new	_	new	_	JJ	1	_	_	_	_	_	_	_	O
35	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
36	development	_	development	_	NN	1	_	_	_	_	_	_	_	O
37	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	upstream	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
2	biotech	_	biotech	_	NN	1	_	_	_	_	_	_	_	O
3	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
4	(	_	(	_	(	1	_	_	_	_	_	_	_	O
5	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
6	,	_	,	_	,	1	_	_	_	_	_	_	_	O
7	upstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
8	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
9	)	_	)	_	)	1	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
11	downstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
12	pharmaceutical	_	pharmaceutical	_	JJ	1	_	_	_	_	_	_	_	O
13	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
14	(	_	(	_	(	1	_	_	_	_	_	_	_	O
15	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
16	,	_	,	_	,	1	_	_	_	_	_	_	_	O
17	downstream	_	UNK	_	FW	1	_	_	_	_	_	_	_	O
18	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
19	)	_	)	_	)	1	_	_	_	_	_	_	_	O
20	often	_	often	_	RB	1	_	_	_	_	_	_	_	O
21	form	_	form	_	JJ	1	_	_	_	_	_	_	_	O
22	alliances	_	alliance	_	NNS	1	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
24	cope	_	UNK	_	VB	1	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
26	performance	_	performance	_	NN	1	_	_	_	_	_	_	_	O
27	uncertainty	_	uncertainty	_	NN	1	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
30	exploit	_	exploit	_	VB	1	_	_	_	_	_	_	_	O
31	product	_	product	_	NN	1	_	_	_	_	_	product.n	Commutative_statement	O
32	specificity	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
33	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
34	new	_	new	_	JJ	1	_	_	_	_	_	_	_	O
35	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
36	development	_	development	_	NN	1	_	_	_	_	_	_	_	O
37	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	upstream	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
2	biotech	_	biotech	_	NN	1	_	_	_	_	_	_	_	O
3	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
4	(	_	(	_	(	1	_	_	_	_	_	_	_	O
5	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
6	,	_	,	_	,	1	_	_	_	_	_	_	_	O
7	upstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
8	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
9	)	_	)	_	)	1	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
11	downstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
12	pharmaceutical	_	pharmaceutical	_	JJ	1	_	_	_	_	_	_	_	O
13	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
14	(	_	(	_	(	1	_	_	_	_	_	_	_	O
15	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
16	,	_	,	_	,	1	_	_	_	_	_	_	_	O
17	downstream	_	UNK	_	FW	1	_	_	_	_	_	_	_	O
18	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
19	)	_	)	_	)	1	_	_	_	_	_	_	_	O
20	often	_	often	_	RB	1	_	_	_	_	_	_	_	O
21	form	_	form	_	JJ	1	_	_	_	_	_	_	_	O
22	alliances	_	alliance	_	NNS	1	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
24	cope	_	UNK	_	VB	1	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
26	performance	_	performance	_	NN	1	_	_	_	_	_	_	_	O
27	uncertainty	_	uncertainty	_	NN	1	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
30	exploit	_	exploit	_	VB	1	_	_	_	_	_	_	_	O
31	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
32	specificity	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
33	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
34	new	_	new	_	JJ	1	_	_	_	_	_	_	_	O
35	product	_	product	_	NN	1	_	_	_	_	_	product.n	Commutative_statement	O
36	development	_	development	_	NN	1	_	_	_	_	_	_	_	O
37	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	upstream	_	UNK	_	NNP	1	_	_	_	_	_	_	_	O
2	biotech	_	biotech	_	NN	1	_	_	_	_	_	_	_	O
3	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
4	(	_	(	_	(	1	_	_	_	_	_	_	_	O
5	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
6	,	_	,	_	,	1	_	_	_	_	_	_	_	O
7	upstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
8	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
9	)	_	)	_	)	1	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
11	downstream	_	UNK	_	JJ	1	_	_	_	_	_	_	_	O
12	pharmaceutical	_	pharmaceutical	_	JJ	1	_	_	_	_	_	_	_	O
13	firms	_	firm	_	NNS	1	_	_	_	_	_	_	_	O
14	(	_	(	_	(	1	_	_	_	_	_	_	_	O
15	i.e.	_	i.e.	_	FW	1	_	_	_	_	_	_	_	O
16	,	_	,	_	,	1	_	_	_	_	_	_	_	O
17	downstream	_	UNK	_	FW	1	_	_	_	_	_	_	_	O
18	partners	_	UNK	_	NNS	1	_	_	_	_	_	_	_	O
19	)	_	)	_	)	1	_	_	_	_	_	_	_	O
20	often	_	often	_	RB	1	_	_	_	_	_	_	_	O
21	form	_	form	_	JJ	1	_	_	_	_	_	_	_	O
22	alliances	_	alliance	_	NNS	1	_	_	_	_	_	_	_	O
23	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
24	cope	_	UNK	_	VB	1	_	_	_	_	_	_	_	O
25	with	_	with	_	IN	1	_	_	_	_	_	_	_	O
26	performance	_	performance	_	NN	1	_	_	_	_	_	_	_	O
27	uncertainty	_	uncertainty	_	NN	1	_	_	_	_	_	_	_	O
28	and	_	and	_	CC	1	_	_	_	_	_	_	_	O
29	to	_	to	_	TO	1	_	_	_	_	_	_	_	O
30	exploit	_	exploit	_	VB	1	_	_	_	_	_	_	_	O
31	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
32	specificity	_	UNK	_	NN	1	_	_	_	_	_	_	_	O
33	in	_	in	_	IN	1	_	_	_	_	_	_	_	O
34	new	_	new	_	JJ	1	_	_	_	_	_	_	_	O
35	product	_	product	_	NN	1	_	_	_	_	_	_	_	O
36	development	_	development	_	NN	1	_	_	_	_	_	development.n	Processing_materials	O
37	.	_	.	_	.	1	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	although.scon	Concessive	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	performance.n	Performing_arts	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	alliance.n	Alliance	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	investigate.v	Research	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	research.n	Research	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	have.v	Possession	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	not.adv	Negation	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	offer.v	Offering	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	of.prep	Age	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	although	_	Although	_	IN	2	_	_	_	_	_	_	_	O
2	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
3	performance	_	performance	_	NN	2	_	_	_	_	_	_	_	O
4	implications	_	UNK	_	NNS	2	_	_	_	_	_	_	_	O
5	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
6	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
7	alliances	_	alliance	_	NNS	2	_	_	_	_	_	_	_	O
8	have	_	have	_	VBP	2	_	_	_	_	_	_	_	O
9	been	_	be	_	VBN	2	_	_	_	_	_	_	_	O
10	investigated	_	investigate	_	VBN	2	_	_	_	_	_	_	_	O
11	,	_	,	_	,	2	_	_	_	_	_	_	_	O
12	research	_	research	_	NN	2	_	_	_	_	_	_	_	O
13	has	_	have	_	VBZ	2	_	_	_	_	_	_	_	O
14	not	_	not	_	RB	2	_	_	_	_	_	_	_	O
15	offered	_	offer	_	VBN	2	_	_	_	_	_	_	_	O
16	insight	_	UNK	_	RB	2	_	_	_	_	_	_	_	O
17	into	_	into	_	IN	2	_	_	_	_	_	_	_	O
18	how	_	how	_	WRB	2	_	_	_	_	_	_	_	O
19	the	_	the	_	DT	2	_	_	_	_	_	_	_	O
20	timing	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
21	of	_	of	_	IN	2	_	_	_	_	_	_	_	O
22	such	_	such	_	JJ	2	_	_	_	_	_	_	_	O
23	unk	_	UNK	_	JJ	2	_	_	_	_	_	_	_	O
24	alliances	_	alliance	_	NNS	2	_	_	_	_	_	alliance.n	Alliance	O
25	influences	_	influence	_	NNS	2	_	_	_	_	_	_	_	O
26	partner	_	UNK	_	NN	2	_	_	_	_	_	_	_	O
27	returns	_	return	_	NNS	2	_	_	_	_	_	_	_	O
28	.	_	.	_	.	2	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	prediction.n	Expectation	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	that.adv	Degree	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	cost.n	Expensiveness	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	benefit.n	Social_event	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	to.prep	Goal	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	that.adv	Degree	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	effect.n	Being_in_effect	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	influence.v	Objective_influence	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	set.n	Aggregate	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	of.prep	Age	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	alliance.n	Alliance	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	_	_	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	the	_	The	_	DT	3	_	_	_	_	_	_	_	O
2	authors	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
3	develop	_	develop	_	VBP	3	_	_	_	_	_	_	_	O
4	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
5	test	_	test	_	VBP	3	_	_	_	_	_	_	_	O
6	predictions	_	prediction	_	NNS	3	_	_	_	_	_	_	_	O
7	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
8	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
9	changes	_	change	_	NNS	3	_	_	_	_	_	_	_	O
10	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
11	costs	_	cost	_	NNS	3	_	_	_	_	_	_	_	O
12	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
13	benefits	_	benefit	_	NNS	3	_	_	_	_	_	_	_	O
14	accruing	_	UNK	_	VBG	3	_	_	_	_	_	_	_	O
15	to	_	to	_	TO	3	_	_	_	_	_	_	_	O
16	upstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
17	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
18	downstream	_	UNK	_	VB	3	_	_	_	_	_	_	_	O
19	partners	_	UNK	_	NNS	3	_	_	_	_	_	_	_	O
20	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
21	that	_	that	_	IN	3	_	_	_	_	_	_	_	O
22	the	_	the	_	DT	3	_	_	_	_	_	_	_	O
23	effect	_	effect	_	NN	3	_	_	_	_	_	_	_	O
24	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
25	timing	_	UNK	_	NN	3	_	_	_	_	_	_	_	O
26	is	_	be	_	VBZ	3	_	_	_	_	_	_	_	O
27	influenced	_	influence	_	VBN	3	_	_	_	_	_	_	_	O
28	by	_	by	_	IN	3	_	_	_	_	_	_	_	O
29	a	_	a	_	DT	3	_	_	_	_	_	_	_	O
30	set	_	set	_	NN	3	_	_	_	_	_	_	_	O
31	of	_	of	_	IN	3	_	_	_	_	_	_	_	O
32	alliance	_	alliance	_	NN	3	_	_	_	_	_	_	_	O
33	,	_	,	_	,	3	_	_	_	_	_	_	_	O
34	firm	_	firm	_	NN	3	_	_	_	_	_	_	_	O
35	,	_	,	_	,	3	_	_	_	_	_	_	_	O
36	and	_	and	_	CC	3	_	_	_	_	_	_	_	O
37	market	_	market	_	NN	3	_	_	_	_	_	_	_	O
38	conditions	_	condition	_	NNS	3	_	_	_	_	_	condition.n	Medical_conditions	O
39	.	_	.	_	.	3	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	event.n	Event	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	study.n	Building_subparts	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	of.prep	Age	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	agreement.n	Be_in_agreement_on_action	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	that.adv	Degree	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	structure.n	Buildings	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	of.prep	Age	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	change.v	Undergo_change	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	achieve.v	Accomplishment	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	_	_	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

1	an	_	An	_	DT	4	_	_	_	_	_	_	_	O
2	event	_	event	_	NN	4	_	_	_	_	_	_	_	O
3	study	_	study	_	NN	4	_	_	_	_	_	_	_	O
4	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
5	276	_	UNK	_	CD	4	_	_	_	_	_	_	_	O
6	unk	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
7	agreements	_	agreement	_	NNS	4	_	_	_	_	_	_	_	O
8	between	_	between	_	IN	4	_	_	_	_	_	_	_	O
9	biotech	_	biotech	_	NN	4	_	_	_	_	_	_	_	O
10	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
11	pharmaceutical	_	pharmaceutical	_	JJ	4	_	_	_	_	_	_	_	O
12	firms	_	firm	_	NNS	4	_	_	_	_	_	_	_	O
13	during	_	during	_	IN	4	_	_	_	_	_	_	_	O
14	1998-2010	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
15	reveals	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
16	that	_	that	_	WDT	4	_	_	_	_	_	_	_	O
17	alliance	_	alliance	_	VBP	4	_	_	_	_	_	_	_	O
18	governance	_	governance	_	NN	4	_	_	_	_	_	_	_	O
19	structure	_	structure	_	NN	4	_	_	_	_	_	_	_	O
20	,	_	,	_	,	4	_	_	_	_	_	_	_	O
21	partner	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
22	technological	_	technological	_	JJ	4	_	_	_	_	_	_	_	O
23	capability	_	capability	_	NN	4	_	_	_	_	_	_	_	O
24	,	_	,	_	,	4	_	_	_	_	_	_	_	O
25	and	_	and	_	CC	4	_	_	_	_	_	_	_	O
26	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
27	competitiveness	_	UNK	_	NN	4	_	_	_	_	_	_	_	O
28	of	_	of	_	IN	4	_	_	_	_	_	_	_	O
29	market	_	market	_	NN	4	_	_	_	_	_	_	_	O
30	environments	_	environment	_	NNS	4	_	_	_	_	_	_	_	O
31	change	_	change	_	VBP	4	_	_	_	_	_	_	_	O
32	the	_	the	_	DT	4	_	_	_	_	_	_	_	O
33	abnormal	_	UNK	_	JJ	4	_	_	_	_	_	_	_	O
34	returns	_	return	_	NNS	4	_	_	_	_	_	_	_	O
35	achieved	_	achieve	_	VBN	4	_	_	_	_	_	_	_	O
36	by	_	by	_	IN	4	_	_	_	_	_	_	_	O
37	partners	_	UNK	_	NNS	4	_	_	_	_	_	_	_	O
38	entering	_	enter	_	VBG	4	_	_	_	_	_	_	_	O
39	these	_	these	_	DT	4	_	_	_	_	_	_	_	O
40	relationships	_	relationship	_	NNS	4	_	_	_	_	_	relationship.n	Cognitive_connection	O
41	in	_	in	_	IN	4	_	_	_	_	_	_	_	O
42	important	_	important	_	JJ	4	_	_	_	_	_	_	_	O
43	ways	_	way	_	NNS	4	_	_	_	_	_	_	_	O
44	.	_	.	_	.	4	_	_	_	_	_	_	_	O

